China Universal Asset Management Company’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
DA
BCC
China Universal Asset Management Company's AMPH Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Amphastar Pharmaceuticals (AMPH) stake by 13% in Q2 2026, selling an estimated $20.9K and leaving 7,017 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #386.
China Universal Asset Management Company first reported a position in AMPH in Q3 2022 and has held it in 16 quarters since. The position peaked at $454K in Q3 2024. 122 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- China Universal Asset Management Company held 7,017 shares of Amphastar Pharmaceuticals worth $142K as of Q2 2026.
- China Universal Asset Management Company sold 1,034 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $20.9K.
- Amphastar Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #386 holding.
- China Universal Asset Management Company first reported a position in Amphastar Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Amphastar Pharmaceuticals position peaked at $454K in Q3 2024.
- 122 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.